Fibrinolytic abnormalities. A Spanish multicenter study ebt.I on 443 patients with venous thromboembolic disease.
Falkon
L
L
Thrombosis and Haemostasis Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Borrell
M
M
Sala
N
N
Felez
J
J
Martín
S
S
Grau
E
E
Fontcuberta
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D004198:Disease Susceptibility; D005342:Fibrinolysis; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis; D015995:Prevalence; D011506:Proteins / Q000032:analysis; D013030:Spain / Q000453:epidemiology; D013923:Thromboembolism / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D013924:Thrombophlebitis / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000032:analysis; D000099053:Histidine-Rich Glycoprotein
D017395:Plasminogen Activator Inhibitor 1; D011506:Proteins; D000099053:Histidine-Rich Glycoprotein; D010958:Plasminogen; D010959:Tissue Plasminogen Activator